Pratham Pharmachem Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -39.89%
- Profit Growth 452.48%
- Ebitda 1114.19%
- Net Worth 1343.20%
- Total Assets -22.63%
About Pratham Pharmachem
Pratham Pharmachem Private Limited (PPPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 July 2011 and has a history of 13 years and six months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jiten Chheda, Krunal Doshi, and Dhawal Mewada serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51101MH2011PTC220196
-
Company No.
220196
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
26 Jul 2011
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Pratham Pharmachem Private Limited offer?
Pratham Pharmachem Private Limited offers a wide range of products and services, including Office Chairs, Executive Chairs, Revolving Chair, High Back Office Chair.
Who are the key members and board of directors at Pratham Pharmachem?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Krunal Doshi | Director | 01-Apr-2015 | Current |
Jiten Chheda | Director | 26-Jul-2011 | Current |
Dhawal Mewada | Director | 01-Apr-2015 | Current |
Financial Performance of Pratham Pharmachem.
Pratham Pharmachem Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 39.89% decrease. The company also saw a substantial improvement in profitability, with a 452.48% increase in profit. The company's net worth Soared by an impressive increase of 1343.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Pratham Pharmachem?
In 2020, Pratham Pharmachem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pratham Pharmachem?
Unlock and access historical data on people associated with Pratham Pharmachem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pratham Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pratham Pharmachem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.